Radio and PodcastRadio and PodcastLive Radio & Podcasts
Adjuvant Androgen Deprivation Therapy No Benefit After Surgery for High-Risk Prostate Cancer artwork
Science & Medicine

Adjuvant Androgen Deprivation Therapy No Benefit After Surgery for High-Risk Prostate Cancer

Oncology Times - OT Broadcasts from the iPad Archives by Oncology Times

Mar 3, 20259:41Science & Medicine

At the 2025 ASCO Genitourinary Cancers Symposium in San Francisco, the Phase III AFU-GETUG-20 trial reported that adjuvant androgen deprivation therapy did not improve outcomes when added to surgery for patients with hig...

Related Episodes

Continue listening to more episodes from Oncology Times - OT Broadcasts from the iPad Archives.